Boosters, Vaccine sera, Neutralization breadth, Titer decay, Omicron, BA.5, BA.2.12.1, BA.1.1, Delta
Tea infusions, COVID-19, BA.1.1.529+R346K, BA.2, BA.2.12.1, BA.4
SARS-CoV-2, Protease inhibitor, Nirmatrelvir, Rebound, Decay, Virus persistence, Half-life, endpoint, immunofluorescence, nucleocapsid
SARS-CoV-2, public antibody, neutralization, yeast display